From the Sector

Reset
1602 results
17.04.2020

BVMed: „in den Kliniken zu einem verantwortbaren Regelbetrieb zurückkehren“

Der Bundesverband Medizintechnologie, BVMed, hat die Äußerungen von Gesundheitsminister Jens Spahn vom 17.04.2020 im ARD-Morgenmagazin und in der RKI-Pressekonferenz unterstützt, schrittweise auch in den Krankenhäusern eine neue Balance zu finden und Operationen wieder aufzunehmen, die die letzten Wochen verschoben wurden. „Wir müssen in den Kliniken wieder zu einem verantwortbaren Regelbetrieb zurückkehren“, so BVMed-Geschäftsführer Dr. Marc-Pierre Möll.

Spahn hatte im Morgenmagazin eine Rückkehr zur Normalität in den Kliniken angedeutet und verwies dabei auf Patienten, deren Tumoroperation oder Eingriffe an Hüftgelenken vor vier Wochen verschoben wurden. Jeder, der einen Herzinfarkt oder Schlaganfall habe oder eine Operation benötige, müsse behandelt werden.

Der Bundesverband Medizintechnologie, BVMed, hat die Äußerungen von Gesundheitsminister Jens Spahn vom 17.04.2020 im ARD-Morgenmagazin und in der RKI-Pressekonferenz unterstützt, schrittweise auch in den Krankenhäusern eine neue Balance zu finden und Operationen wieder aufzunehmen, die die letzten Wochen verschoben wurden. „Wir müssen in den Kliniken wieder zu einem verantwortbaren Regelbetrieb zurückkehren“, so BVMed-Geschäftsführer Dr. Marc-Pierre Möll.

Spahn hatte im Morgenmagazin eine Rückkehr zur Normalität in den Kliniken angedeutet und verwies dabei auf Patienten, deren Tumoroperation oder Eingriffe an Hüftgelenken vor vier Wochen verschoben wurden. Jeder, der einen Herzinfarkt oder Schlaganfall habe oder eine Operation benötige, müsse behandelt werden.

Die Verschiebung von Operationen betrifft nach Ansicht des BVMed beispielsweise die Bereiche Onkologie, Kardiologie, Neurochirurgie, Orthopädie oder Ophthalmologie. Möll: „Es zeigt sich, dass die Bettenkapazitäten sehr unterschiedlich ausgelastet sind – und es daher auch Freiräume gibt, um rasch medizinische Eingriffe in Krankenhäusern und ambulanten Einrichtungen wieder zu ermöglichen. Das ist wichtig, um ein Fortschreiten von Krankheiten zu verhindern und Patienten von Einschränkungen und Schmerzen zu befreien.“

Für Kliniken und ambulante Einrichtungen sollten entsprechende Anreize geschaffen werden, um verschobene Operationen schnellstmöglich nachzuholen. Sinnvoll sind regionale Vereinbarungen, welche Krankenhäuser in welcher Reihenfolge die COVID-19-Patientenversorgung übernehmen und welche Krankenhäuser planbare Operationen wieder aufnehmen können. Hierbei sollten Aspekte wie Dringlichkeit, durchschnittlich kurze Inanspruchnahme intensivmedizinischer Kapazitäten sowie kurze Krankenhausverweildauern in die Priorisierung einbezogen werden. Zudem ist die Liefersicherheit von Medizinprodukten zu beachten, denn Lieferketten wurden unterbrochen und müssen für den Neustart vorbereitet werden, zumal Lieferanten und Vorproduktion oftmals aus dem Ausland kommen.

More information:
Coronavirus
Source:

BVMed - Bundesverband Medizintechnologie e.V.
 

16.04.2020

Rieter Annual General Meeting 2020

  • All motions approved
  • Dividend of CHF 4.50 agreed
  • COVID-19

In relation to participation in the Annual General Meeting on April 16, 2020, the Board of Directors of Rieter Holding Ltd. arranged exclusively written or electronic voting and the granting of power of attorney to the independent proxy. In taking this approach, the Board of Directors relied on Article 6a, lit. b of Ordinance 2 of the Swiss Federal Council (Measures to Combat the Coronavirus of March 16, 2020). Physical participation by the shareholders was therefore not possible. The Annual General Meeting was held on the premises of Rieter Holding Ltd. at the company’s headquarters in Winterthur.

At the Annual General Meeting of Rieter Holding Ltd. on April 16, 2020, the independent proxy represented a total of 2 025 shareholders who hold 64.3% of the share capital.

A dividend of CHF 4.50 per share was agreed. The shareholders approved the proposed maximum total amounts of the remuneration of the members of the Board of Directors and of the Group Executive Committee for fiscal year 2021.

  • All motions approved
  • Dividend of CHF 4.50 agreed
  • COVID-19

In relation to participation in the Annual General Meeting on April 16, 2020, the Board of Directors of Rieter Holding Ltd. arranged exclusively written or electronic voting and the granting of power of attorney to the independent proxy. In taking this approach, the Board of Directors relied on Article 6a, lit. b of Ordinance 2 of the Swiss Federal Council (Measures to Combat the Coronavirus of March 16, 2020). Physical participation by the shareholders was therefore not possible. The Annual General Meeting was held on the premises of Rieter Holding Ltd. at the company’s headquarters in Winterthur.

At the Annual General Meeting of Rieter Holding Ltd. on April 16, 2020, the independent proxy represented a total of 2 025 shareholders who hold 64.3% of the share capital.

A dividend of CHF 4.50 per share was agreed. The shareholders approved the proposed maximum total amounts of the remuneration of the members of the Board of Directors and of the Group Executive Committee for fiscal year 2021.

The Chairman of the Board, Bernhard Jucker, and the members of the Board of Directors This E. Schneider, Michael Pieper, Hans-Peter Schwald, Peter Spuhler, Roger Baillod, Carl Illi and Luc Tack were confirmed for an additional one-year term of office.
Furthermore, This E. Schneider, Hans-Peter Schwald and Bernhard Jucker, the members of the Remuneration Committee who were standing for election, were also each re-elected for a one-year term of office.

Shareholders also adopted all other motions proposed by the Board of Directors, namely approval of the annual report, the financial statements and the consolidated financial statements for 2019, and formal approval of the actions of the members of the Board of Directors and those of the Group Executive Committee in the year under review. In addition, the authorized capital was extended for a further two years.

COVID-19
At present, it is not possible to predict how the global COVID-19 pandemic will affect Rieter’s sales and earnings in the first and second half of 2020, and thus also for 2020 as a whole.

Rieter therefore refrains from providing an outlook for financial year 2020 and will issue the relevant information as part of the semi-annual report on July 16, 2020.
The company has taken the necessary measures to protect employees and to meet commitments to customers as far as possible.

Thanks to long-standing customer relationships, a focus on innovation, global positioning and the company’s financial stability, Rieter will successfully overcome the challenges.

More information:
Rieter Rieter Holding Ltd.
Source:

Rieter Management AG

16.04.2020

SANITIZED AG aids measures to promote hygiene management during the coronavirus pandemic

  • Antiviral properties of Sanitized® products on synthetics validated

Tests conducted by independent laboratories have now confirmed that a treatment with Sanitized® T 99-19 and Sanitized® T 11-15 reduces the viral load on PES textiles by
up to 99 %.

Swiss company SANITIZED AG announces the validation from impartial labs that Sanitized®T 99-19 and Sanitized®T 11-15 are also effective against viruses (in accordance with ISO 18184:2019). Tests were performed using a feline coronavirus with structures and mechanisms reminiscent of SARS-Cov2. Patented technology featuring an ammonium silicate compound  is employed in Sanitized®T 99-19 and Sanitized®T 11-15 utilizes tried and tested silver technology.

These additives are the perfect tool for an antiviral and antibacterial treatment of face masks, protective professional medical clothing, bed linens, or mattresses. The formulation of both products remains completely untouched, thus ensuring that it will continue to offer outstanding protection against bacteria.

  • Antiviral properties of Sanitized® products on synthetics validated

Tests conducted by independent laboratories have now confirmed that a treatment with Sanitized® T 99-19 and Sanitized® T 11-15 reduces the viral load on PES textiles by
up to 99 %.

Swiss company SANITIZED AG announces the validation from impartial labs that Sanitized®T 99-19 and Sanitized®T 11-15 are also effective against viruses (in accordance with ISO 18184:2019). Tests were performed using a feline coronavirus with structures and mechanisms reminiscent of SARS-Cov2. Patented technology featuring an ammonium silicate compound  is employed in Sanitized®T 99-19 and Sanitized®T 11-15 utilizes tried and tested silver technology.

These additives are the perfect tool for an antiviral and antibacterial treatment of face masks, protective professional medical clothing, bed linens, or mattresses. The formulation of both products remains completely untouched, thus ensuring that it will continue to offer outstanding protection against bacteria.

Before a final product’s antiviral properties can be publicly promoted, viral tests must be performed in specialized laboratories. Compliance with local legal regulations is essential here. SANITIZED AG explicitly points out that this is standard procedure and has composed a preliminary Guide for Treating PPE (personal protective equipment) with biocide products.

Guide Link: https://campaign.sanitized.com/en/treatment-of-ppe-with-biocidal-products

More information:
Coronavirus
Source:

PR-Büro Heinhöfer

Logo Sanitized
Logo Sanitized
16.04.2020

Sanitized: Antiviral properties of Sanitized® products on synthetics

Tests conducted by independent laboratories have now confirmed that a treatment with Sanitized® T 99-19 and Sanitized® T 11-15 reduces the viral load on PES textiles by up to 99 %.

Swiss company SANITIZED AG celebrates validation from impartial labs that Sanitized®T 99-19 and Sanitized®T 11-15 are also effective against viruses (in accordance with ISO 18184:2019).
Tests were performed using a feline coronavirus with structures and mechanisms reminiscent of SARS-Cov2.

Patented technology featuring an ammonium silicate compound is employed in Sanitized®T 99-19 and Sanitized®T 11-15 utilizes tried and tested silver technology. These additives are the perfect tool for an antiviral and antibacterial treatment of face masks, protective professional medical clothing, bed linens, or mattresses.
The formulation of both products remains completely untouched, thus ensuring that it will continue to offer outstanding protection against bacteria.

Tests conducted by independent laboratories have now confirmed that a treatment with Sanitized® T 99-19 and Sanitized® T 11-15 reduces the viral load on PES textiles by up to 99 %.

Swiss company SANITIZED AG celebrates validation from impartial labs that Sanitized®T 99-19 and Sanitized®T 11-15 are also effective against viruses (in accordance with ISO 18184:2019).
Tests were performed using a feline coronavirus with structures and mechanisms reminiscent of SARS-Cov2.

Patented technology featuring an ammonium silicate compound is employed in Sanitized®T 99-19 and Sanitized®T 11-15 utilizes tried and tested silver technology. These additives are the perfect tool for an antiviral and antibacterial treatment of face masks, protective professional medical clothing, bed linens, or mattresses.
The formulation of both products remains completely untouched, thus ensuring that it will continue to offer outstanding protection against bacteria.

Before a final product’s antiviral properties can be publicly promoted, viral tests must be performed in specialized laboratories. Compliance with local legal regulations is essential here. SANITIZED AG explicitly points out that this is standard procedure and has composed a preliminary Guide for Treating PPE

SANITIZED AG has been supporting the work of hygienists in hospitals, doctor’s offices, nursing and care facilities for many years with its antimicrobial - and now also antiviral - additives used to enhance the
functionality of textiles and polymers. The reduction of bacteria and viruses is a feasible way to help stem the spread of infections including MRSA.

Source:

PR-Büro Heinhöfer

PINKO Logo
Pinko receives important certification
14.04.2020

PINKO receives a certification of the Shanghai Municipality

Pinko is glad to announce that its Chinese subsidiary, Cris Conf Retail, received from the highest office in the Shanghai municipality the “Shanghai Multinational Company Headquarter” certification.

At the presence of Shanghai mayor, Gong Zheng, Cris Conf Retail obtained this status thanks to its investment projects for the creation of a central headquarter in the Chinese city, which will be the primary hub for the management and commercial development of Pinko’s operations across the Asian market. Through this important recognition, Pinko and its parent company Cris Conf confirm the strategic importance of the Chinese market in the brand’s global internalization process.

Thanks to the “Shanghai Multinational Company Headquarter” certification, Pinko will have access to a range of benefits in China, including facilitated import and custom procedures, as well as expedited clearance for the company’s staff upon arrival in China and a direct channel of communication with Chinese national offices.

Pinko currently operates 72 stores in China, located in the most important cities and at the most prestigious malls and department stores.

Pinko is glad to announce that its Chinese subsidiary, Cris Conf Retail, received from the highest office in the Shanghai municipality the “Shanghai Multinational Company Headquarter” certification.

At the presence of Shanghai mayor, Gong Zheng, Cris Conf Retail obtained this status thanks to its investment projects for the creation of a central headquarter in the Chinese city, which will be the primary hub for the management and commercial development of Pinko’s operations across the Asian market. Through this important recognition, Pinko and its parent company Cris Conf confirm the strategic importance of the Chinese market in the brand’s global internalization process.

Thanks to the “Shanghai Multinational Company Headquarter” certification, Pinko will have access to a range of benefits in China, including facilitated import and custom procedures, as well as expedited clearance for the company’s staff upon arrival in China and a direct channel of communication with Chinese national offices.

Pinko currently operates 72 stores in China, located in the most important cities and at the most prestigious malls and department stores.

More information:
PINKO certification China
Source:

NETWORK PUBLIC RELATIONS GMBH

Die CHIC Messe wird aufgrund der Corona-Pandemie verschoben (c) CHIC
CHIC Messe
09.04.2020

Nachholtermin CHIC Shanghai, März 2020

Die Märzveranstaltung der CHIC Shanghai wird im Juli in Shenzhen stattfinden. Aufgrund der globalen Corona Epidemie konnte die Mode- und Lifestyle Messe CHIC Shanghai nicht wie geplant vom 11. bis 13. März 2020 in Shanghai veranstaltet werden.

Die weiter anhaltende weltweite epidemische Situation lässt nicht zu, dass Chinas Kontroll- und Präventionsmaßnahmen gelockert werden. Es ist aus logistischen Gründen nicht möglich, den Nachholtermin der Frühjahrsveranstaltung der CHIC März noch vor der Herbstveranstaltung der CHIC Shanghai im September in Shanghai stattfinden zu lassen.

Die ursprünglich geplante Veranstaltungsfläche für die Premiere der CHIC Shenzhen vom 15. bis 17. Juli 2020 wird um 10.000 Quadratmeter auf 40.000 Quadratmeter erweitert.Das Konzept, ein Ort - ein Datum - vier Shows, das sich in Shanghai seit Jahren bewährt hat, wird hier fortgesetzt.

Die Märzveranstaltung der CHIC Shanghai wird im Juli in Shenzhen stattfinden. Aufgrund der globalen Corona Epidemie konnte die Mode- und Lifestyle Messe CHIC Shanghai nicht wie geplant vom 11. bis 13. März 2020 in Shanghai veranstaltet werden.

Die weiter anhaltende weltweite epidemische Situation lässt nicht zu, dass Chinas Kontroll- und Präventionsmaßnahmen gelockert werden. Es ist aus logistischen Gründen nicht möglich, den Nachholtermin der Frühjahrsveranstaltung der CHIC März noch vor der Herbstveranstaltung der CHIC Shanghai im September in Shanghai stattfinden zu lassen.

Die ursprünglich geplante Veranstaltungsfläche für die Premiere der CHIC Shenzhen vom 15. bis 17. Juli 2020 wird um 10.000 Quadratmeter auf 40.000 Quadratmeter erweitert.Das Konzept, ein Ort - ein Datum - vier Shows, das sich in Shanghai seit Jahren bewährt hat, wird hier fortgesetzt.

Die "Greater Bay Textile & Apparel Expo" des China National Textile and Apparel Council wird insgesamt vier Trade Shows kombinieren:
China International Fashion Fair 2020 in Shenzhen (CHIC SHENZHEN), Intertextile SHENZHEN Apparel Fabrics, PH Value (Shenzhen) und Greater Bay Area International Trade Fair for Fibres and Yarns.

CHIC ist eng mit den Mode- und Textilindustrieclustern der Pearl River Delta-Region verbunden und bietet insbesondere Marktmöglichkeiten für die Regionen Guangdong - Hongkong - Macao - Greater Bay.

In den Hallen 9 und 11 des Shenzhen World Exhibition & Convention Centers sind alle Produktbereiche der CHIC geplant: CHIC Tailoring, Urban View (Menswear), New Look (Womenswear), Impulses (Designerbereich), CHIC Kidz, CHIC-Young Blood, CHIC Worldwide (internationale Beteiligungen) in Halle 9 und Denim World, Secret Stars (Accessoires), Bags & Shoes, Heritage (Leder, Pelz und Daunen), ODM in Halle 11.
CHIC SHOWS und CHIC TALK werden ebenfalls in Shenzhen präsentiert. Parallel bietet CHIC die Möglichkeit zur Teilnahme an der CHIC Online vom 22. bis 24. April 2020 an. Hierfür werden alle Ressourcen und Netzwerke der CHIC für ein Business-Matching der Teilnehmer genutzt.

Der Termin der Herbstveranstaltung der CHIC in Shanghai ist für den 23. bis 25. September 2020 geplant. Veranstalter sind die China National Garment Association, Sub-Council of Textile Industry CCPIT und China World Trade Center Co. Ltd.

Source:

JANDALI MODE.MEDIEN.MESSEN

Logo Fairfield
Fairfield produces surgical gowns
08.04.2020

Fairfield Chair Pivots from Seating Production to Surgical Gowns

Fairfield Chair Co. has retooled its production of chairs and sofas to high-in-demand surgical gowns in an effort to help rush supplies to health care companies on the frontline of the COVID-19 pandemic.

When the spread of the coronavirus impacted Fairfield and the entire U.S. manufacturing sector, Fairfield executives jumped into action.

The seating manufacturer, which essentially took a crash course on apparel patternmaking and industry specs, has switched its production to surgical gowns overnight. In just over a week, Fairfield produced its first samples of the surgical gown and immediately received approval on the prototype from Blue Ridge Healthcare in North Carolina, which has placed an initial order for 1,200 surgical gowns.
Cotswold Industries worked closely with Fairfield to help the company pivot to gown and mask manufacturing and provide the materials needed for the finished products.

Fairfield Chair Co. has retooled its production of chairs and sofas to high-in-demand surgical gowns in an effort to help rush supplies to health care companies on the frontline of the COVID-19 pandemic.

When the spread of the coronavirus impacted Fairfield and the entire U.S. manufacturing sector, Fairfield executives jumped into action.

The seating manufacturer, which essentially took a crash course on apparel patternmaking and industry specs, has switched its production to surgical gowns overnight. In just over a week, Fairfield produced its first samples of the surgical gown and immediately received approval on the prototype from Blue Ridge Healthcare in North Carolina, which has placed an initial order for 1,200 surgical gowns.
Cotswold Industries worked closely with Fairfield to help the company pivot to gown and mask manufacturing and provide the materials needed for the finished products.

Fairfield is also tapping into the experience it gained from producing seating for senior living facilities, which require certain materials with antimicrobial finishes.
“We are very accustomed to working with antimicrobial fabrics however, we have never worked with wovens that are developed to meet specifications like this material has to,” states McClurd, vice President of imports of Fairfield.

More information:
corona virus respiratory masks
Source:

NCTO

Logos of the participating companies
Gerber PPE Task Force
08.04.2020

A&E and Burlington participate in the Gerber PPE Task Force

Elevate Textiles, a global provider of advanced, high quality products and mission critical textile solutions is pleased to participate in the recently launched Gerber PPE Task Force. This industry-wide effort combines resources and expertise to support manufacturing operations and brands as they increase their production or transition their operations to produce personal protective equipment in the fight against COVID-19.
Elevate’s Burlington, American & Efird (A&E), and Gütermann brands provide critical barrier fabric and thread components used in the manufacturing of lifesaving PPE products including masks, isolation gowns and other medical garments.

"The only way to be successful during this difficult situation is to join forces and support one another," said Lenny Marano, VP of Product Management & Marketing for Automation Systems at Gerber Technology. "We are proud to have a global network of partners to support PPE production so that it's more widely available."

Elevate Textiles, a global provider of advanced, high quality products and mission critical textile solutions is pleased to participate in the recently launched Gerber PPE Task Force. This industry-wide effort combines resources and expertise to support manufacturing operations and brands as they increase their production or transition their operations to produce personal protective equipment in the fight against COVID-19.
Elevate’s Burlington, American & Efird (A&E), and Gütermann brands provide critical barrier fabric and thread components used in the manufacturing of lifesaving PPE products including masks, isolation gowns and other medical garments.

"The only way to be successful during this difficult situation is to join forces and support one another," said Lenny Marano, VP of Product Management & Marketing for Automation Systems at Gerber Technology. "We are proud to have a global network of partners to support PPE production so that it's more widely available."

For over 40 years, Burlington has been in the Medical business manufacturing fabrics for use in operating theaters such as surgeon’s gowns, isolation gowns, sterilization wrapper packs, drapes, scrubs and lab coats. The Maxima® collection of fabrics is useful for reusable isolation and surgical gowns and meets AAMI standards for Levels 1-4 and FDA standards.

Source:

American & Efird

07.04.2020

COVID-19 | BVMed: GKV sollen Kosten für Schutzausrüstung für Homecare übernehmen

Der Bundesverband Medizintechnologie, BVMed, hat den GKV-Spitzenverband in einem Schreiben gebeten, analog zu dem Vorgehen bei Kassenärzten, Kassenzahnärzten und Pflegepersonal auch die Kosten für die Ausstattung der Fachkräfte der Homecare-Unternehmen mit medizinischer Schutzausrüstung zu übernehmen. Homecare müsste dafür Teil der Verteilung von Schutzausrüstung durch das Beschaffungsamt des Innenministeriums werden. "Eine solche Maßnahme würde den ambulanten Verbleib der zu Hause versorgten Patienten sichern, die Kliniken entlasten und die Homecare-Unternehmen bei ihrem Mehraufwand unterstützen", so BVMed-Geschäftsführer Dr. Marc-Pierre Möll.

Vor dem Hintergrund der Coronavirus-Pandemie hat der GKV-Spitzenverband bereits eine Unterstützung der Kassenärzte, der Kassenzahnärzte sowie des Pflegepersonals bei der Ausstattung und insbesondere bei Abrechnung und Finanzierung der erforderlichen Schutzausrüstung vereinbart. "Diese Entscheidung halten wir für sinnvoll, um die Gesundheitsversorgung sicherzustellen und dabei die Infektionsrisiken für Gesundheitspersonal und Patienten zu reduzieren", schreibt der BVMed.

Der Bundesverband Medizintechnologie, BVMed, hat den GKV-Spitzenverband in einem Schreiben gebeten, analog zu dem Vorgehen bei Kassenärzten, Kassenzahnärzten und Pflegepersonal auch die Kosten für die Ausstattung der Fachkräfte der Homecare-Unternehmen mit medizinischer Schutzausrüstung zu übernehmen. Homecare müsste dafür Teil der Verteilung von Schutzausrüstung durch das Beschaffungsamt des Innenministeriums werden. "Eine solche Maßnahme würde den ambulanten Verbleib der zu Hause versorgten Patienten sichern, die Kliniken entlasten und die Homecare-Unternehmen bei ihrem Mehraufwand unterstützen", so BVMed-Geschäftsführer Dr. Marc-Pierre Möll.

Vor dem Hintergrund der Coronavirus-Pandemie hat der GKV-Spitzenverband bereits eine Unterstützung der Kassenärzte, der Kassenzahnärzte sowie des Pflegepersonals bei der Ausstattung und insbesondere bei Abrechnung und Finanzierung der erforderlichen Schutzausrüstung vereinbart. "Diese Entscheidung halten wir für sinnvoll, um die Gesundheitsversorgung sicherzustellen und dabei die Infektionsrisiken für Gesundheitspersonal und Patienten zu reduzieren", schreibt der BVMed.

In gleicher Situation befinden sich auch die Fachkräfte der Homecare-Unternehmen, die Patienten vor Ort mit den erforderlichen Hilfs- und Verbandmitteln, enteraler Ernährung sowie den hierfür erforderlichen Dienstleistungen versorgen. Die Empfehlungen des GKV-Spitzenverbandes zur Sicherung der Hilfsmittelversorgung während COVID-19 sehen zwar bereits Regelungsvorschläge vor, um den physischen Kontakt zwischen Versorgern und Patienten zu reduzieren. Die persönliche Versorgung am Patienten ist im Homecare-Bereich aber teilweise unverzichtbar. Dies betrifft beispielsweise die Bereiche Beatmungstherapie, Tracheostoma-Versorgung, künstliche Ernährung, Wund- und Stomaversorgung bei Komplikationen, notwendige rehatechnische Versorgungen sowie die Versorgung von Patienten im Rahmen des Entlassmanagements.

"Aufgrund der aktuellen Beschaffungslage und preislicher Entwicklungen von Schutzausrüstungen entsteht den Hilfsmittelleistungserbringern und Homecare-Unternehmen zunehmend eine Situation, in der sie die erforderliche Versorgung am Patienten nicht sicherstellen können", informiert der BVMed. Deshalb sei eine Lösung analog zu den Ärzten und Zahnärzten auf der Grundlage der durch das Beschaffungsamt des Bundesinnenministeriums beschafften Schutzausrüstung sinnvoll. Der BVMed bietet als maßgebliche Spitzenorganisation der Hilfsmittelleistungserbringer auf Bundesebene seine Unterstützung bei der Koordination an. Alternativ wäre auch eine individuelle Bezuschussung der Hilfsmittelleistungserbringer und Homecare-Unternehmen denkbar.

 

More information:
Homecare Coronavirus
Source:

BVMed - Bundesverband Medizintechnologie e.V.

02.04.2020

Predictive maintenance reduces downtime on PCMC’s Xcut saw

New tissue log saw allows operators to track critical component lifecycles

Paper Converting Machine Company (PCMC), part of Barry-Wehmiller, has announced that the Xcut saw, its newest tissue log saw, now has the ability to use predictive maintenance to reduce unplanned downtime.

With this new capability, operators will be able to track the lifecycles of critical components and monitor the performance of others. The saw will provide notifications regarding upcoming maintenance requirements before they become critical issues, allowing operators to have replacement parts ready when the time comes.

The Xcut saw will monitor and collect information from servo motor feedback, vibration sensors and other devices, and alert operators when the machine needs maintenance. For example, if an axis becomes more difficult to turn or experiences abnormal vibrations, the predictive maintenance system will provide an alert that the gearbox may need to be replaced.

New tissue log saw allows operators to track critical component lifecycles

Paper Converting Machine Company (PCMC), part of Barry-Wehmiller, has announced that the Xcut saw, its newest tissue log saw, now has the ability to use predictive maintenance to reduce unplanned downtime.

With this new capability, operators will be able to track the lifecycles of critical components and monitor the performance of others. The saw will provide notifications regarding upcoming maintenance requirements before they become critical issues, allowing operators to have replacement parts ready when the time comes.

The Xcut saw will monitor and collect information from servo motor feedback, vibration sensors and other devices, and alert operators when the machine needs maintenance. For example, if an axis becomes more difficult to turn or experiences abnormal vibrations, the predictive maintenance system will provide an alert that the gearbox may need to be replaced.

This multifaceted approach to predictive maintenance allows operators to tackle multiple maintenance tasks at the same time, which reduces downtime and gets the machine back into production more quickly.

More information:
textile machinery
Meltblown Vliesstoffanlagen von Oerlikon Nonwoven (c) Oerlikon Manmade fibers
Meltblown Vliesstoffanlagen von Oerlikon Nonwoven
02.04.2020

Oerlikon Nonwoven large-scale meltblown sold to Asia

a leading Asian large-scale manufacturer of manmade fibers and polymers has invested in a new Oerlikon Nonwoven meltblown system. The recently-signed contract comprises a 2-beam system for manufacturing filtration nonwovens – predominantly for medical products such as face masks – with a nominal capacity of up to 1,200 tons of nonwovens a year. The commercial production launch has been scheduled for the fourth quarter of 2020.

The 2-beam system has an operating width of 1.6 meters and is equipped with the new patented Oerlikon Nonwoven electro-charging unit. The Oerlikon Nonwoven meltblown technology is recognized by the market as being the technically most efficient method for producing highly-separating filter media made from manmade fibers, particularly in conjunction with electrostatic charging and with extremely low-pressure loss. Electro-charging the filter nonwovens allows the manufacture of sophisticated EPA- and HEPA-class filter media as well as media that comply with the requirements of N95-, FFP2- and FFP3-class respiratory masks.

a leading Asian large-scale manufacturer of manmade fibers and polymers has invested in a new Oerlikon Nonwoven meltblown system. The recently-signed contract comprises a 2-beam system for manufacturing filtration nonwovens – predominantly for medical products such as face masks – with a nominal capacity of up to 1,200 tons of nonwovens a year. The commercial production launch has been scheduled for the fourth quarter of 2020.

The 2-beam system has an operating width of 1.6 meters and is equipped with the new patented Oerlikon Nonwoven electro-charging unit. The Oerlikon Nonwoven meltblown technology is recognized by the market as being the technically most efficient method for producing highly-separating filter media made from manmade fibers, particularly in conjunction with electrostatic charging and with extremely low-pressure loss. Electro-charging the filter nonwovens allows the manufacture of sophisticated EPA- and HEPA-class filter media as well as media that comply with the requirements of N95-, FFP2- and FFP3-class respiratory masks.

The demand for filtration nonwovens for medical applications has risen tremendously across the globe since the outbreak of the Sars-CoV-2 (coronavirus) epidemic, presenting all manufacturers with huge challenges. A meltblown system will be commissioning at the site of a leading Western European nonwovens producers as early as the second quarter of 2020. This system will be deployed exclusively in the manufacture of nonwovens for respiratory masks.

Due to the current state of emergency with regards to the local supply of face masks, Oerlikon Nonwoven is currently using its own laboratory system to produce electrostatically-charged filter media which are being sent to local small businesses and companies for the manufacture of face masks. 

 

More information:
Oerlikon Nonwoven
Source:

Oerlikon Manmade fibers

02.04.2020

NCTO Statement on Administration’s Reported Tariff Deferral

The National Council of Textile Organizations (NCTO), representing the full spectrum of U.S. textiles from fiber through finished products, issued a statement from NCTO President and CEO Kim Glas today in response to the administration’s plan to institute a 90-day deferral on MFN tariffs,  as reported by numerous press outlets.

The reported plan being pushed by the importing and retailing industries would defer certain tariffs, including those on finished apparel products. It is an ill-advised policy that will hurt the U.S. textile industry at the very time it is answering the call of the nation to produce medical supplies to battle the coronavirus pandemic. 

These unnecessary tariff concessions would benefit importers and retailers at the direct expense of manufacturers on the front lines of the COVID-19 response and send a demoralizing message.

Tariff deferrals would severely exacerbate ramifications for the U.S. economy, manufacturers and workers and open the floodgates for imports.

The National Council of Textile Organizations (NCTO), representing the full spectrum of U.S. textiles from fiber through finished products, issued a statement from NCTO President and CEO Kim Glas today in response to the administration’s plan to institute a 90-day deferral on MFN tariffs,  as reported by numerous press outlets.

The reported plan being pushed by the importing and retailing industries would defer certain tariffs, including those on finished apparel products. It is an ill-advised policy that will hurt the U.S. textile industry at the very time it is answering the call of the nation to produce medical supplies to battle the coronavirus pandemic. 

These unnecessary tariff concessions would benefit importers and retailers at the direct expense of manufacturers on the front lines of the COVID-19 response and send a demoralizing message.

Tariff deferrals would severely exacerbate ramifications for the U.S. economy, manufacturers and workers and open the floodgates for imports.

If the U.S. government makes tariff concessions during this crisis, it will be inviting a virtual tsunami of imports further devastating domestic manufacturing as it attempts to regain its footing.     

We urge the administration to abandon any moves to defer tariffs on finished products. It would only serve to allow importers to exploit the current crisis, while dealing a severe blow to U.S. manufacturing and its workers.  

NCTO is a Washington, DC-based trade association that represents domestic textile manufacturers, including artificial and synthetic filament and fiber producers. 

  • U.S. employment in the textile supply chain was 585,240 in 2019. 
  • The value of shipments for U.S. textiles and apparel was $75.8 billion in 2019. 
  • U.S. exports of fiber, textiles and apparel were $29.1 billion in 2019. 
  • Capital expenditures for textile and apparel production totaled $2.5 billion in 2018, the last year for which data is available.
More information:
NCTO Coronavirus
Source:

NCTO

Logo BVMed
BVMed über den MedTech-Standort Deutschland
02.04.2020

BVMed: MedTech-Standort Deutschland und seine kritische Infrastruktur

Der Bundesverband Medizintechnologie, BVMed, fordert in seinem neuen Jahresbericht 2019/20 einen gesamtgesellschaftlichen Dialog über den MedTech-Standort Deutschland und seine kritische Infrastruktur.

Das Gesundheitssystem kämpft aktuell gegen eine der schlimmsten Pandemien der letzten 100 Jahre. Die MedTech-Branche ist vereint in ihrem Kampf gegen COVID-19. Die Unterstützung der Ärzte und Pfleger, der Kliniken, Praxen und Homecare-Unternehmen, hat oberste Priorität. Gleichzeitig muss die MedTech-Branche die nahtlose Verfügbarkeit aller medizinischen Technologien aufrechterhalten, die Tag für Tag für die Diagnose, Behandlung und Überwachung von Patienten mit anderen kritischen oder chronischen Erkrankungen benötigt werden.

In seinem Vorwort spricht sich der BVMed-Vorstandsvorsitzende Dr. Meinrad Lugan insbesondere für eine bessere Verzahnung der regulatorischen Maßnahmen für die Medizinprodukte-Branche mit der Wirtschafts- und Forschungspolitik aus. Forschung, Wirtschaft und Gesundheit gemeinsam.

Zu den Themen des notwendigen "MedTech-Dialogs" gehören nach Ansicht des BVMed beispielsweise:

Der Bundesverband Medizintechnologie, BVMed, fordert in seinem neuen Jahresbericht 2019/20 einen gesamtgesellschaftlichen Dialog über den MedTech-Standort Deutschland und seine kritische Infrastruktur.

Das Gesundheitssystem kämpft aktuell gegen eine der schlimmsten Pandemien der letzten 100 Jahre. Die MedTech-Branche ist vereint in ihrem Kampf gegen COVID-19. Die Unterstützung der Ärzte und Pfleger, der Kliniken, Praxen und Homecare-Unternehmen, hat oberste Priorität. Gleichzeitig muss die MedTech-Branche die nahtlose Verfügbarkeit aller medizinischen Technologien aufrechterhalten, die Tag für Tag für die Diagnose, Behandlung und Überwachung von Patienten mit anderen kritischen oder chronischen Erkrankungen benötigt werden.

In seinem Vorwort spricht sich der BVMed-Vorstandsvorsitzende Dr. Meinrad Lugan insbesondere für eine bessere Verzahnung der regulatorischen Maßnahmen für die Medizinprodukte-Branche mit der Wirtschafts- und Forschungspolitik aus. Forschung, Wirtschaft und Gesundheit gemeinsam.

Zu den Themen des notwendigen "MedTech-Dialogs" gehören nach Ansicht des BVMed beispielsweise:

  • eine stärkere Orientierung an kompletten Versorgungsprozessen,
  • die Reduktion regulatorischer Bürokratie für Bestandsprodukte und Orphan Devices,
  • die Entwicklungen von digitalen Gesundheitsdienstleistungen und
  • die Einbindung von künstlicher Intelligenz zur Unterstützung von ärztlicher Versorgung und Pflege.


Der BVMed-Jahresbericht beleuchtet die wichtigsten Branchen-Kennzahlen
Die MedTech-Branche ist ein wichtiger Wirtschafts- und Arbeitsmarktfaktor. Die Branche beschäftigt in Deutschland insgesamt über 200.000 Menschen. Alleine in den letzten 5 Jahren sind über 12.000 neue Stellen geschaffen worden. Jeder Arbeitsplatz in der Branche sichert zudem 0,75 Arbeitsplätze in anderen Sektoren. Der Gesamtumsatz der MedTech-Branche lag 2019 bei über 32 Milliarden Euro. Die Exportquote liegt bei über 65 Prozent.
Die MedTech-Branche ist mittelständisch geprägt. 93 Prozent der MedTech-Unternehmen beschäftigen weniger als 250 Mitarbeiter. Es gibt alleine 13.000 Kleinstunternehmen mit rund 60.000 Beschäftigten. Nur 90 MedTech-Unternehmen in Deutschland haben über 250 Beschäftigte.   

Der Jahresbericht kann in deutscher und englischer Sprache unter www.bvmed.de/jahresbericht heruntergeladen werden.

Source:

BVMed - Bundesverband Medizintechnologie e.V.

Sherrod Brown (c) NCTO
25.03.2020

Brown pushing plan to address shortage of personal protective equipment

Brown Wrote to President Outlining Critical Steps White House can Take Now to Address Shortage of Personal Protective Equipment

 U.S. Sen. Sherrod Brown (D-OH) hosted a news conference call to discuss his plan for addressing the shortage of personal protective equipment (PPE) needed by healthcare workers on the frontline of keeping Americans healthy and safe during the coronavirus pandemic.

This weekend, Brown wrote to President Trump outlining several steps the Administration should take immediately to address the shortage and ramp up manufacturing of these critical medical supplies.

Brown Wrote to President Outlining Critical Steps White House can Take Now to Address Shortage of Personal Protective Equipment

 U.S. Sen. Sherrod Brown (D-OH) hosted a news conference call to discuss his plan for addressing the shortage of personal protective equipment (PPE) needed by healthcare workers on the frontline of keeping Americans healthy and safe during the coronavirus pandemic.

This weekend, Brown wrote to President Trump outlining several steps the Administration should take immediately to address the shortage and ramp up manufacturing of these critical medical supplies.

In his plan and in his letter to the President, Brown lists nine steps the Administration could take immediately, including:

  1. Designate a government official who can serve as a point person responsible for coordination the acquisition and development of PPE, medical devices, and other supplies necessary to fight the coronavirus pandemic. 
  2. Establish a PPE and medical device assessment and database to monitor the supply and anticipated needs for PPE, ventilators, diagnostic test kits, and other needed medical supplies to respond to the coronavirus pandemic. 
  3. Publish a list of PPE, medical device, and general medical supply needs to respond to the coronavirus pandemic. 
  4. Establish a hotline capable of handling significant call capacity that will provide U.S. producers centralized information about the results of the national assessment and the current need for PPE, devices, and other health care supplies. 
  5. Provide immediate funding to manufacturers to purchase equipment, retool machinery, hire additional workers, and cover any other expenses needed to increase production of PPE and necessary medical devices and supplies.
  6. Streamline contract and certification procedures to ensure production and delivery of materials are not delayed due to paperwork constraints.
  7. Provide critical protections for workers who are making PPE, medical devices, and necessary supplies to receive a waiver from any shelter-in-place requirements to allow workers to volunteer to go to work in these critical industries. 
  8. Provide purchase guarantees and delivery assistance of product to the communities and health care facilities that need the products most. 
  9. Support companies that have the capacity to sterilize reusable equipment to alleviate the existing PPE shortage. 

In his plan, Brown also pointed out important legislative actions that will help ramp up production of these critical supplies, including expanding the strategic national stockpile authority, substantially increasing Defense Production Act funding and strengthening domestic preferences.

More information:
NCTO Coronavirus United States
Source:

NCTO

NCTO (c) NCTO
23.03.2020

Beverly Knits Inc. produces face masks for health care workers

Beverly Knits Inc. is proud to be involved in the effort led by Hanes and Parkdale to help support the fight against COVID-19. Working with a coalition of textile companies, we are ramping up production in the USA to provide face masks for health care workers on the frontlines. With the combined efforts of many small and medium-size companies, we are retooling our production lines to begin manufacturing immediately.

Beverly Knits is coordinating the production of up to 1.5 million masks produced domestically per week. Ron Sytz, CEO of Beverly Knits, said “It is an honor to be working with great American companies, united to supply critical resources to healthcare workers and first responders”.

Companies on the Beverly Knits team

  • Clover Knits
  • Contempora Knits
  • Carolina Cotton Works
  • Southfork Finishing
  • National Safety Apparel
  • A Lava & Sons
  • Wells Hosiery
  • Jomel Industries
  • LA Corp
  • Greenwood Mills

 

Beverly Knits Inc. is proud to be involved in the effort led by Hanes and Parkdale to help support the fight against COVID-19. Working with a coalition of textile companies, we are ramping up production in the USA to provide face masks for health care workers on the frontlines. With the combined efforts of many small and medium-size companies, we are retooling our production lines to begin manufacturing immediately.

Beverly Knits is coordinating the production of up to 1.5 million masks produced domestically per week. Ron Sytz, CEO of Beverly Knits, said “It is an honor to be working with great American companies, united to supply critical resources to healthcare workers and first responders”.

Companies on the Beverly Knits team

  • Clover Knits
  • Contempora Knits
  • Carolina Cotton Works
  • Southfork Finishing
  • National Safety Apparel
  • A Lava & Sons
  • Wells Hosiery
  • Jomel Industries
  • LA Corp
  • Greenwood Mills

 

More information:
Beverly Knits Inc. NCTO
Source:

NCTO

22.03.2020

USA: Call of Nation to Produce Medical Face Masks

Coalition of Iconic American Apparel Brands & Textile Companies Heeds Call of Nation to Produce Medical Face Masks

A coalition of iconic American apparel brands and textile companies, responding to the urgent call of the White House for medical supplies, have come together to build a supply chain virtually overnight and fast-track the manufacturing of medical face masks to help hospitals, health care workers and citizens battling the spread of the COVID-19 disease.

Parkdale Inc.-- the largest yarn spinner in the U.S. headquartered in North Carolina—helped lead the effort to build the coalition with Hanesbrands, Fruit of the Loom and six other companies to set up a manufacturing supply chain and begin ramping up production of the masks.

The coalition consists of iconic American brands such as Hanesbrands and Fruit of the Loom, often competitors in the marketplace, who are banding together for the greater good of a nation facing one if its most monumental challenges.

Coalition of Iconic American Apparel Brands & Textile Companies Heeds Call of Nation to Produce Medical Face Masks

A coalition of iconic American apparel brands and textile companies, responding to the urgent call of the White House for medical supplies, have come together to build a supply chain virtually overnight and fast-track the manufacturing of medical face masks to help hospitals, health care workers and citizens battling the spread of the COVID-19 disease.

Parkdale Inc.-- the largest yarn spinner in the U.S. headquartered in North Carolina—helped lead the effort to build the coalition with Hanesbrands, Fruit of the Loom and six other companies to set up a manufacturing supply chain and begin ramping up production of the masks.

The coalition consists of iconic American brands such as Hanesbrands and Fruit of the Loom, often competitors in the marketplace, who are banding together for the greater good of a nation facing one if its most monumental challenges.

American Giant, Los Angeles Apparel, AST Sportswear, Sanmar, America Knits, Beverly Knits and Riegel Linen are also part of the coalition working tirelessly to respond to a national emergency in the nation’s time of need.

Dr. Peter Navarro, assistant to the President and director of the White House Office of Trade and Manufacturing Policy, worked with the coalition and helped expedite the production of these masks. The first face masks have been approved by the U.S. Department of Health and Human Services.

The companies expect to begin production on Monday and will make the first deliveries by mid-week.

They are dedicating their assets, resources and manufacturing capacities to create a high output of facemasks. Once fully ramped up in four to five weeks, the companies expect to produce up to 10 million facemasks per week in the United States and in Central America.

If companies are interested in dedicating resources to help the cause, please reach out to the National Council of Textile Organizations at kellis@ncto.org

NCTO is a Washington, DC-based trade association that represents domestic textile manufacturers, including artificial and synthetic filament and fiber producers.
 

  • U.S. employment in the textile supply chain was 594,147 in 2018.  
  • The value of shipments for U.S. textiles and apparel was $76.8 billion in 2018.  
  • U.S. exports of fiber, textiles and apparel were $30.1 billion in 2018.  
  • Capital expenditures for textile and apparel production totaled $2.0 billion in 2017, the last year for which data is available.
Source:

National Council of Textile Organizations

NCTO Logo (c) NCTO
NCTO Logo
20.03.2020

U.S. Textile and Nonwoven Associations Urge Government to Deem Manufacturing

Textile and nonwoven associations issued a joint statement today urging federal, state and local governments to deem textile and nonwoven manufacturing facilities as “essential” when drafting “Shelter in Place” orders in response to the COVID-19 crisis.

Our associations recognize the serious challenges our elected officials, health administrators, and others are facing when issuing orders to protect communities across the country and we understand the necessity for leaders to enforce a ‘Shelter in Place” order or quarantine orders.

Our members make a broad range of inputs and finished products used in an array of personal protective equipment (PPE) and medical nonwoven/textile supplies, including surgical gowns, face masks, antibacterial wipes, lab coats, blood pressure cuffs, cotton swabs and hazmat suits. These items are vital to the government’s effort to ramp up emergency production of these critical supplies.

Textile and nonwoven associations issued a joint statement today urging federal, state and local governments to deem textile and nonwoven manufacturing facilities as “essential” when drafting “Shelter in Place” orders in response to the COVID-19 crisis.

Our associations recognize the serious challenges our elected officials, health administrators, and others are facing when issuing orders to protect communities across the country and we understand the necessity for leaders to enforce a ‘Shelter in Place” order or quarantine orders.

Our members make a broad range of inputs and finished products used in an array of personal protective equipment (PPE) and medical nonwoven/textile supplies, including surgical gowns, face masks, antibacterial wipes, lab coats, blood pressure cuffs, cotton swabs and hazmat suits. These items are vital to the government’s effort to ramp up emergency production of these critical supplies.

If workers who produce these goods are not granted an “essential” exemption from “Shelter in Place” and other quarantine orders to go to their manufacturing and distribution facilities, it will cause major disruptions in the availability of these goods. This will create significant hardship to healthcare providers and consumers across the country who depend on steady and stable supplies of these critical items.

We are asking the administration and state and local authorities to provide greater certainty and clarity for our companies and employees and ask for a clear exclusion of our manufacturing operations from “Shelter in Place” orders as the textile and nonwoven products that we make in the U.S. play an essential role in mitigating the shortages of critical supplies. Such a designation will help us avoid disruptions of vital goods and services during this challenging time.

Source:

NCTO

IFAI 

INDA

A modern hydroponic herb growing facility. (c) AWOL
A modern hydroponic herb growing facility.
20.03.2020

Salad days for the UK’s Anglo Recycling

Anglo Recycling Technology is on course to deliver no less than a million of its special nonwoven mats for hydroponically growing herbs to a major customer in the Middle East this year. The Growfelt-branded products arose from the discovery back in the late 1990s by Anglo Recycling’s owner Simon Macaulay, that the Sussex-based retail supplier of salads, Van Heineken Brothers (now Vitacress), used nonwoven felts on which to grow its cress.

“I drove down to see the company’s production manager, Chris Moncrieff and discovered they were indeed growing cress on felts, but they were made from virgin materials and he liked the idea of maybe using a blend of virgin fiber offcuts of cotton, wool, and polypropylene,” he explains. “That’s how Growfelt was born. For the first six years, we supplied exclusively to Vitacress and in return, they helped us to bring our factory up to food-grade standard and to set in place a testing regime for Salmonella E-Coli coliforms and listeria.”

Anglo Recycling Technology is on course to deliver no less than a million of its special nonwoven mats for hydroponically growing herbs to a major customer in the Middle East this year. The Growfelt-branded products arose from the discovery back in the late 1990s by Anglo Recycling’s owner Simon Macaulay, that the Sussex-based retail supplier of salads, Van Heineken Brothers (now Vitacress), used nonwoven felts on which to grow its cress.

“I drove down to see the company’s production manager, Chris Moncrieff and discovered they were indeed growing cress on felts, but they were made from virgin materials and he liked the idea of maybe using a blend of virgin fiber offcuts of cotton, wool, and polypropylene,” he explains. “That’s how Growfelt was born. For the first six years, we supplied exclusively to Vitacress and in return, they helped us to bring our factory up to food-grade standard and to set in place a testing regime for Salmonella E-Coli coliforms and listeria.”

In recent years, however, Anglo Recycling, which is based in Whitworth, near Rochdale in the UK, has significantly broadened its customer base. It now offers a core of three growing media products to meet the differing needs of customers across Europe, the Middle East, and the Far East, whether for retail presentation and appearance or for water holding.

 

More information:
Anglo Recycling Technology
Source:

AWOL

NCTO Logo
NCTO sees the manifacturing facilities as "essential"
19.03.2020

U.S. Textile and Nonwoven Associations Urge Government to Deem Manufacturing Facilities “Essential”

The U.S. textile and nonwoven associations NCTO, IFAL and INDA issued a joint statement today urging federal, state and local governments to deem textile and nonwoven manufacturing facilities as “essential” when drafting “Shelter in Place” orders in response to the COVID-19 crisis.

The associations recognize the serious challenges of the elected officials, health administrators and others are facing when issuing orders to protect communities across the country and show understanding for the necessity to enforce quarantine orders.

The U.S. textile and nonwoven associations NCTO, IFAL and INDA issued a joint statement today urging federal, state and local governments to deem textile and nonwoven manufacturing facilities as “essential” when drafting “Shelter in Place” orders in response to the COVID-19 crisis.

The associations recognize the serious challenges of the elected officials, health administrators and others are facing when issuing orders to protect communities across the country and show understanding for the necessity to enforce quarantine orders.

The members of these associations are part of the production of personal protective equipment (PPE) and medical nonwoven/textile supplies, including surgical gowns, face masks, antibacterial wipes, lab coats, blood pressure cuffs, cotton swabs and hazmat suits. These items are vital to the government’s effort to ramp up emergency production of these critical supplies.
If workers who produce these goods are not granted an “essential” exemption from “Shelter in Place” and other quarantine orders to go to their manufacturing and distribution facilities, it will cause major disruptions in the availability of these goods, states the association. This will create hardship to healthcare providers and consumers across the country who depend on steady and stable supplies of these critical items, says the NCTO.

More information:
Coronavirus NCTO face masks USA
Source:

National Council of Textile Organizations

Yarn (c) Sateri
Yarn
18.03.2020

Sateri Achieves Breakthrough in Commercial Production of Viscose Using Recycled Textile Waste

Forging Ahead with Circular Bioeconomy

Sateri, the world ’ s largest producer of viscose, has successfully produced on commercial scale viscose fiber regenerated from textile waste. The high-quality new fiber uses a mix of dissolving pulp made from recycled post-consumer textile waste by Swedish company Södra, and other PEFC - certified wood pulp.

Trialed at Sateri ’ s Linz Nanjng yarn spinning mill using two advanced technologies, Siro compact and Vortex, the new fiber has proven compatibility with existing spinning technologies, ensuring stable yarn production without the need to adjust existing processes or parameters. The fiber also has excellent spinning efficiency and delivers yarn evenness and tenacity.

Forging Ahead with Circular Bioeconomy

Sateri, the world ’ s largest producer of viscose, has successfully produced on commercial scale viscose fiber regenerated from textile waste. The high-quality new fiber uses a mix of dissolving pulp made from recycled post-consumer textile waste by Swedish company Södra, and other PEFC - certified wood pulp.

Trialed at Sateri ’ s Linz Nanjng yarn spinning mill using two advanced technologies, Siro compact and Vortex, the new fiber has proven compatibility with existing spinning technologies, ensuring stable yarn production without the need to adjust existing processes or parameters. The fiber also has excellent spinning efficiency and delivers yarn evenness and tenacity.

Sateri ’ s breakthrough comes on the back of RGE’s announcement in October last year of a USD200 million investment towards next-generation cellulosic fiber innovation. Sateri is working with several dissolving pulp producers using various innovative technologies to aid the push towards a circular bio-economy. Sateri will be partnering yarn customers, garment manufacturer s and fashion brands to market and officially launch this new recycled viscose fiber product in the coming months, with the eventual goal of making recycled fiber available to the mass market.

More information:
Sateri
Source:

Sateri